enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Next-generation drug from Eli Lilly boosts weight loss to 24% ......

   www.cnn.com/2023/06/26/health/weight-loss-next-gen-triple-g-lilly

   Eli Lilly’s Mounjaro, cleared for type 2 diabetes and awaiting FDA approval for weight loss, targets both GLP-1 and a hormone called GIP, and has produced weight loss of 21 to 23%.

3. A Vibrating Pill Could Be the Next Big Thing for Obesity...

   www.verywellhealth.com/new-vibrating-pill-curbs-food-consumption-8424558

   As a medical device, a vibrating pill for weight management could strike a balance between obesity surgery and medication. Currently, there are only three FDA-regulated devices that have been approved for weight loss: The vibrating pill relies on natural body signaling and could overcome some limitations of current obesity treatments.

4. Obesity (Excessively Overweight): Health Effects and Next Steps -...

   www.webmd.com/obesity/what-obesity-is

   Some drugs the FDA has approved to treat obesity are: Benzphetamine (Didrex, Regimex) Buproprion-naltrexone (Contrave) Cellulose and citric acid (Plenity) Diethylpropion (Depletite, Radtue,...

5. 8 FDA-Approved Drugs for Weight Management - Verywell Health

   www.verywellhealth.com/7-fda-approved-drugs-for-weight-management-7568596

   This article will discuss eight current Food and Drug Administration (FDA)–approved weight loss drugs on the market.

6. New Oral Weight Loss Drugs: Where Are We and What's Next? - ...

   www.medscape.com/viewarticle/new-oral-weight-loss-drugs-where-are-we-and-whats...

   Now that semaglutide (Wegovy), tirzepatide (Zepbound), and other injectables have created an insatiable market for weight loss drugs, biotech and pharmaceutical companies are roaring ahead...

7. FDA Approves New Medication for Chronic Weight Management

   www.fda.gov/.../fda-approves-new-medication-chronic-weight-management

   The FDA approved Zepbound (tirzepatide) injection for chronic weight management in adults with obesity or overweight with at least one weight-related condition, for use in addition to a...